These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37907500)

  • 1. Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
    Khalifa A; Guijarro A; Ravera S; Bertola N; Adorni MP; Papotti B; Raffaghello L; Benelli R; Becherini P; Namatalla A; Verzola D; Reverberi D; Monacelli F; Cea M; Pisciotta L; Bernini F; Caffa I; Nencioni A
    Nat Commun; 2023 Oct; 14(1):6951. PubMed ID: 37907500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
    Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
    JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity.
    Khalifa A; Guijarro A; Ravera S; Bertola N; Adorni MP; Papotti B; Raffaghello L; Benelli R; Becherini P; Namatalla A; Verzola D; Reverberi D; Monacelli F; Cea M; Pisciotta L; Bernini F; Caffa I; Nencioni A
    Nat Commun; 2023 Nov; 14(1):7614. PubMed ID: 37993421
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience.
    Eur Heart J; 1999 May; 20(10):725-41. PubMed ID: 10329064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
    Fuentes-Fayos AC; G-García ME; Pérez-Gómez JM; Montero-Hidalgo AJ; Martín-Colom J; Doval-Rosa C; Blanco-Acevedo C; Torres E; Toledano-Delgado Á; Sánchez-Sánchez R; Peralbo-Santaella E; Ortega-Salas RM; Jiménez-Vacas JM; Tena-Sempere M; López M; Castaño JP; Gahete MD; Solivera J; Luque RM
    EBioMedicine; 2023 Apr; 90():104484. PubMed ID: 36907105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
    Noutsou M; Georgopoulos A
    J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumour activity of doxorubicin and simvastatin combination loaded nanoemulsion treatment against a Swiss albino mouse model of Ehrlich ascites carcinoma.
    Alkreathy HM; Alkhatib MH; Al Musaddi SA; Balamash KSA; Osman NN; Ahmad A
    Clin Exp Pharmacol Physiol; 2019 May; 46(5):496-505. PubMed ID: 30724380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p.
    Bai F; Yu Z; Gao X; Gong J; Fan L; Liu F
    Aging (Albany NY); 2019 May; 11(10):3198-3219. PubMed ID: 31138773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
    Kater AL; Batista MC; Ferreira SR
    Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
    Fraunberger P; Gröne E; Gröne HJ; Walli AK
    Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting-mimicking diet and hormone therapy induce breast cancer regression.
    Caffa I; Spagnolo V; Vernieri C; Valdemarin F; Becherini P; Wei M; Brandhorst S; Zucal C; Driehuis E; Ferrando L; Piacente F; Tagliafico A; Cilli M; Mastracci L; Vellone VG; Piazza S; Cremonini AL; Gradaschi R; Mantero C; Passalacqua M; Ballestrero A; Zoppoli G; Cea M; Arrighi A; Odetti P; Monacelli F; Salvadori G; Cortellino S; Clevers H; De Braud F; Sukkar SG; Provenzani A; Longo VD; Nencioni A
    Nature; 2020 Jul; 583(7817):620-624. PubMed ID: 32669709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase inhibitors on the concentration of insulin-like growth factor-1 (IGF-1) in hypercholesterolemic patients.
    Szkodziński J; Romanowski W; Hudzik B; Kaszuba A; Nowakowska-Zajdel E; Szkilnik R; Pietrasińska B; Zubelewicz-Szkodzińska B
    Pharmacol Rep; 2009; 61(4):654-64. PubMed ID: 19815947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH; Jeng CY; Lee WJ; Lin SY; Pei D; Chen YT
    Metabolism; 2001 Mar; 50(3):355-9. PubMed ID: 11230791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transcriptomic analysis of turmeric: Curcumin represses the expression of cholesterol biosynthetic genes and synergizes with simvastatin.
    Einbond LS; Manservisi F; Wu HA; Balick M; Antonetti V; Vornoli A; Menghetti I; Belpoggi F; Redenti S; Roter A
    Pharmacol Res; 2018 Jun; 132():176-187. PubMed ID: 29408497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.
    Moutzouri E; Liberopoulos E; Mikhailidis DP; Kostapanos MS; Kei AA; Milionis H; Elisaf M
    Int J Clin Pract; 2011 Nov; 65(11):1141-8. PubMed ID: 21995692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.